阿摩線上測驗
登入
阿摩線上測驗
登入
試卷名稱：111年 - 111 國立臺灣大學_碩士班招生考試：生命科學#125366
年份：111年
科目：研究所、轉學考(插大)◆生命科學
19. Regarding to the statements of the onco-immunology (IO), which are CORRECT?
(A) PD1/PDL1 is the immune checkpoint pathway
(B) Antibody to stimulate the PD1 has shown the therapeutic benefit for cancer patients
(C) Activation or up-regulation of PDL1 in tumor cells could inhibit the T-cell activation
(D) Lower level of PDL1 in tumor tissues might show the better outcome of patients with cancer immunotherapy (e.g., Pembrolizumab)
(E) The adverse effects of the cancer immunotherapies include interstitial pneumonitis
